Phase III randomized trial of Thal+ZLD versus ZLD in patients with asymptomatic multiple myeloma - updated results after 18-year follow-up.
Nadine H AbdallahThomas E WitzigShaji K KumarMartha Q LacySuzanne R HaymanAngela DispenzieriVivek RoyMorie A GertzPeter Leif BergsagelSundararajan Vincent RajkumarPublished in: Leukemia (2024)